Literature DB >> 16319306

Soluble beta-amyloid1-40 induces NMDA-dependent degradation of postsynaptic density-95 at glutamatergic synapses.

F Roselli1, M Tirard, J Lu, P Hutzler, P Lamberti, P Livrea, M Morabito, O F X Almeida.   

Abstract

Amyloid-beta (Abeta) has been implicated in memory loss and disruption of synaptic plasticity observed in early-stage Alzheimer's disease. Recently, it has been shown that soluble Abeta oligomers target synapses in cultured rat hippocampal neurons, suggesting a direct role of Abeta in the regulation of synaptic structure and function. Postsynaptic density-95 (PSD-95) is a postsynaptic scaffolding protein that plays a critical role in synaptic plasticity and the stabilization of AMPA (AMPARs) and NMDA (NMDARs) receptors at synapses. Here, we show that exposure of cultured cortical neurons to soluble oligomers of Abeta(1-40) reduces PSD-95 protein levels in a dose- and time-dependent manner and that the Abeta1(1-40)-dependent decrease in PSD-95 requires NMDAR activity. We also show that the decrease in PSD-95 requires cyclin-dependent kinase 5 activity and involves the proteasome pathway. Immunostaining analysis of cortical cultured neurons revealed that Abeta treatment induces concomitant decreases in PSD-95 at synapses and in the surface expression of the AMPAR glutamate receptor subunit 2. Together, these data suggest a novel pathway by which Abeta triggers synaptic dysfunction, namely, by altering the molecular composition of glutamatergic synapses.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16319306      PMCID: PMC6725651          DOI: 10.1523/JNEUROSCI.3034-05.2005

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  116 in total

1.  Preparation and characterization of toxic Abeta aggregates for structural and functional studies in Alzheimer's disease research.

Authors:  Asad Jan; Dean M Hartley; Hilal A Lashuel
Journal:  Nat Protoc       Date:  2010-06-03       Impact factor: 13.491

2.  Cerebrospinal fluid levels of Aβ42 relationship with cholinergic cortical activity in Alzheimer's disease patients.

Authors:  Alessandro Martorana; Zaira Esposito; Francesco Di Lorenzo; Viola Giacobbe; Giulia Maria Sancesario; Giulia Bucchi; Sonia Bonnì; Sergio Bernardini; Roberto Sorge; Giuseppe Sancesario; Giorgio Bernardi; Carlo Caltagirone; Giacomo Koch
Journal:  J Neural Transm (Vienna)       Date:  2012-03-09       Impact factor: 3.575

Review 3.  Alzheimer's disease, β-amyloid, glutamate, NMDA receptors and memantine--searching for the connections.

Authors:  Wojciech Danysz; Chris G Parsons
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

Review 4.  The Essential Role of Soluble Aβ Oligomers in Alzheimer's Disease.

Authors:  Zi-Xuan Wang; Lan Tan; Jinyuan Liu; Jin-Tai Yu
Journal:  Mol Neurobiol       Date:  2015-04-02       Impact factor: 5.590

5.  Spatial relationship between synapse loss and beta-amyloid deposition in Tg2576 mice.

Authors:  Hongxin Dong; Maureen V Martin; Shawn Chambers; John G Csernansky
Journal:  J Comp Neurol       Date:  2007-01-10       Impact factor: 3.215

6.  Impaired spine stability underlies plaque-related spine loss in an Alzheimer's disease mouse model.

Authors:  Tara L Spires-Jones; Melanie Meyer-Luehmann; Jennifer D Osetek; Phillip B Jones; Edward A Stern; Brian J Bacskai; Bradley T Hyman
Journal:  Am J Pathol       Date:  2007-08-23       Impact factor: 4.307

7.  Hsp90 chaperone inhibitor 17-AAG attenuates Aβ-induced synaptic toxicity and memory impairment.

Authors:  Yaomin Chen; Bin Wang; Dan Liu; Jing Jing Li; Yueqiang Xue; Kazuko Sakata; Ling-qiang Zhu; Scott A Heldt; Huaxi Xu; Francesca-Fang Liao
Journal:  J Neurosci       Date:  2014-02-12       Impact factor: 6.167

8.  β-amyloid impairs the regulation of N-methyl-D-aspartate receptors by glycogen synthase kinase 3.

Authors:  Yulei Deng; Zhe Xiong; Paul Chen; Jing Wei; Shengdi Chen; Zhen Yan
Journal:  Neurobiol Aging       Date:  2013-10-01       Impact factor: 4.673

Review 9.  Amyloid-Beta and Phosphorylated Tau Accumulations Cause Abnormalities at Synapses of Alzheimer's disease Neurons.

Authors:  Ravi Rajmohan; P Hemachandra Reddy
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

10.  Inhibition of the Motor Protein Eg5/Kinesin-5 in Amyloid β-Mediated Impairment of Hippocampal Long-Term Potentiation and Dendritic Spine Loss.

Authors:  Ronald K Freund; Emily S Gibson; Huntington Potter; Mark L Dell'Acqua
Journal:  Mol Pharmacol       Date:  2016-03-08       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.